Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

4 Emergency Medical Care Rulings You Don't Want To Miss No Photo Available

Gianna Ferrarin

Following a Michigan appellate court's recent finding that evidence brought in a wrongful death suit against paramedics was enough to ... (more story)

This Week's Healthcare Earnings: HCA, Roche, And More No Photo Available

Yeji Jesse Lee

A handful of pharma companies and a slew of health systems released their financial reports this quarter in recent days, kicking off t... (more story)

MAHA, Telehealth And Deals: The Forecast From HLTH No Photo Available

Yeji Jesse Lee

With the close of the annual HLTH conference in Las Vegas, Law360 Healthcare Authority talked with healthcare lawyers and business lea... (more story)